Literature DB >> 9291463

Expression of homeobox genes, including an insulin promoting factor, in the murine yolk sac at the time of hematopoietic initiation.

K E McGrath1, J Palis.   

Abstract

The visceral yolk sac (YS), a simple bilayer structure formed during gastrulation, supplies blood cells and intestine- and liver-like functions to support embryonic growth. To better understand gene regulation in extraembryonic tissues, we examined the early murine YS for expression of the homeobox family of developmental transcription regulators. We identified a subset of known homeobox sequences (Hox 1l, b1, a9, c9, a7, b7, b8, a10, cdx-1, and PDX-1), as well as two novel homeodomains consisting of a fourth labial class Hox genes and one that matches the Antennapedia class on the amino acid level. The two most frequently isolated YS Hox genes, a9 and c9, are initially expressed only in the YS (E.5) and subsequently expressed in both the embryo and YS (E8.5). Another of the identified genes, PDX-1, is involved in pancreatic development and insulin regulation. Whereas the4 rodent YS is known to produce insulin from mid to late gestation, YS insulin expression had not been examined earlier in development . We detected insulin mRNA in the YS at both E7.5 and E8.5, prior to expression in the embryo proper or formation of the pancreas. However, other pancreatic products, such as glucagon, somatostatin, and carboxypeptidase A, are not expressed in the YS. In situ analysis indicates insulin is produced in YS mesothelial cells and endoderm cells, but not in blood cells. We hypothesize the early expression of insulin in the YS is required for the expansion of insulin responsive cells including primitive erythroblasts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291463     DOI: 10.1002/(SICI)1098-2795(199710)48:2<145::AID-MRD1>3.0.CO;2-S

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  7 in total

Review 1.  Deriving and identifying hepatocytes from embryonic stem cells.

Authors:  Alistair J Watt; Lesley M Forrester
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 2.  Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells.

Authors:  Igor I Slukvin
Journal:  Blood       Date:  2013-10-11       Impact factor: 22.113

3.  Single-cell joint detection of chromatin occupancy and transcriptome enables higher-dimensional epigenomic reconstructions.

Authors:  Haiqing Xiong; Yingjie Luo; Qianhao Wang; Xianhong Yu; Aibin He
Journal:  Nat Methods       Date:  2021-05-06       Impact factor: 28.547

Review 4.  Making HSCs in vitro: don't forget the hemogenic endothelium.

Authors:  Bradley W Blaser; Leonard I Zon
Journal:  Blood       Date:  2018-08-08       Impact factor: 22.113

5.  HNF-6-independent differentiation of mouse embryonic stem cells into insulin-producing cells.

Authors:  N Houard; G G Rousseau; F P Lemaigre
Journal:  Diabetologia       Date:  2003-02-27       Impact factor: 10.122

Review 6.  De novo generation of HSCs from somatic and pluripotent stem cell sources.

Authors:  Linda T Vo; George Q Daley
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

7.  Transient gene delivery for functional enrichment of differentiating embryonic stem cells.

Authors:  Eric J Wallenstein; Jeffrey Barminko; Rene S Schloss; Martin L Yarmush
Journal:  Biotechnol Bioeng       Date:  2008-12-01       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.